Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Although several studies have found a high incidence of coexisting mental health problems among adolescents with substance use problems, follow-up studies addressing how these conditions change ove

Original research | 2022
Youth, Mental health, About PWUD

Barriers are prevalent in less populated areas where treatment options are limited.

Original research | 2022
About PWUD, Barriers and enablers, Substitution/OAT

This study examined the perspective of 163 American Indian and Alaska Native people (AIAN) in California to assess culturally based or traditional healing treatment modalities to treat opioid/subst

Original research | 2022
Indigenous, About PWUD, Barriers and enablers
Guidelines | 2021
Clinical guidance, Policy/Regulatory, About prescribers, Illegal drugs, Substitution/OAT, Carries/take-home doses
Guidelines | 2021
Clinical guidance, Policy/Regulatory, About prescribers, Substitution/OAT, Carries/take-home doses, Illegal drugs
Guidelines | 2022
Clinical guidance, Policy/Regulatory, About prescribers, Harm reduction, Safer supply, Carries/take-home doses, Substitution/OAT
Guidelines | 2022
Clinical guidance, Carries/take-home doses, Policy/Regulatory

In March 2020, the Substance Abuse and Mental Health Services Administration (SAMHSA) issued guidance allowing for the expansion of take-home methadone doses.

Original research | 2021
Substitution/OAT, Carries/take-home doses, About PWUD

To limit COVID-19 spread and to avoid disruptions in access to medications for opioid use disorder (MOUD), including buprenorphine and methadone, US federal and state agencies granted unprecedented

Original research | 2022
Carries/take-home doses, About prescribers, About PWUD, Substitution/OAT

We conducted three independent studies on the expanded take-home dose (THD) exemptions to assess implementation and impact on patients and providers in three geographically diverse opioid treatment

Original research | 2022
Substitution/OAT, Carries/take-home doses, Policy/Regulatory, About prescribers, About PWUD, Legal system/law enforcement

This study aimed to describe changes implemented by programs prescribing pharmaceutical alternatives to the drug supply during the early stages of the COVID-19 pandemic.

Original research | 2022
Safer supply, About prescribers, Transitions in care/treatment

To describe the prevalence of incarceration among survivors of non-fatal overdose addressed through an emergency medical services (EMS) response, and compare incarceration by whether the emergency

Original research | 2022
Overdose, About PWUD, Legal system/law enforcement
Training | 2022
Illegal drugs, Hallucinogens/psychedelics

This review aimed to evaluate the evidence base supporting the feasibility and clinical effectiveness of all forms of deprescribing initiatives used to discontinue long-term (≥4 weeks) benzodiazepi

Lit review | 2022
Withdrawal, About prescribers, Outcomes, Transitions in care/treatment

Cette étude a permis d’analyser un large éventail de blessures et d’intoxications liées à la consommation de cocaïne seule et en combinaison avec d’autres substances au Canada, à l’aide des données

Recherche | 2022
les stimulants, les hôpitals, la surdose, les drogues illégales

This study examined a wide range of injuries and poisonings related to cocaine only and in combination with other substances in Canada using sentinel surveillance data captured by the electronic Ca

Original research | 2022
Stimulants, Hospitals, Overdose, Illegal drugs

The authors aimed to determine whether flexible take-home buprenorphine/naloxone is as effective as supervised methadone in reducing opioid use in prescription-type opioid consumers with opioid use

Original research | 2022
Substitution/OAT, About PWUD, Outcomes, Carries/take-home doses
Training | 2022
About prescribers, Safer supply, Policy/Regulatory

We used propensity score (PS) weighting methods to address two methodological questions: (1) Do disparities between sexual minority women (SMW) and heterosexual women persist when differences in ri

Original research | 2022
About PWUD, 2SLGBTQI+, Sex/Gender

Affiner votre recherche

Mots clés
Format
Région